ENTITY

Halozyme Therapeutics (HALO US)

28
Analysis
Health Care • United States
Halozyme Therapeutics, Inc. is a biopharmaceutical company developing products for the diabetes, cancer, dermatology and drug delivery markets. The Company's platform technology is based on recombinant human hyaluronidase plus additional enzymes. Halozyme applies its technology to its proprietary programs and to partnerships with pharmaceutical companies.
more
Company Event • 03 Nov 2026 05:30 • Upcoming
Add To Calendar

Q3 2026

Company Event • 17 Feb 2027 05:00 • Upcoming
Add To Calendar

Q4 2026

Company Event • 16 Sep 2026 22:00 • Latest

H.C. Wainwright 28th Annual Global Investment Conference

Company Event • 15 Sep 2026 19:45

Morgan Stanley 24th Annual Global Healthcare Conference

Company Event • 10 Sep 2026 03:45

Wells Fargo 21st Annual Healthcare Conference

x